PASTEUR Act of 2026
S. 4875 would create a PHSA–funded program to develop innovative antimicrobials targeting hard-to-treat, high-risk pathogens, accelerating resistance‑fighting options.
S. 4875 would create a PHSA–funded program to develop innovative antimicrobials targeting hard-to-treat, high-risk pathogens, accelerating resistance‑fighting options.
WeVote — Public opinion
No community votes yet. Be the first to weigh in from the Vote tab.
Versions
Bill text & amendments
The official bill text and any amendments will be posted here once available.